서브메뉴
검색
Engineering Staphylococcus Epidermidis for the Treatment of Diabetes
Engineering Staphylococcus Epidermidis for the Treatment of Diabetes
상세정보
- 자료유형
- 학위논문 서양
- 최종처리일시
- 20250211152743
- ISBN
- 9798342113441
- DDC
- 600
- 서명/저자
- Engineering Staphylococcus Epidermidis for the Treatment of Diabetes
- 발행사항
- [Sl] : Stanford University, 2024
- 발행사항
- Ann Arbor : ProQuest Dissertations & Theses, 2024
- 형태사항
- 162 p
- 주기사항
- Source: Dissertations Abstracts International, Volume: 86-04, Section: B.
- 주기사항
- Advisor: Endy, Drew.
- 학위논문주기
- Thesis (Ph.D.)--Stanford University, 2024.
- 초록/해제
- 요약Diabetes is a chronic endocrine disease characterized by insulin deficiency and resulting elevated blood glucose levels. Diabetics depend on exogenous injections of insulin to manage blood glucose levels and survive longer term. Poorly controlled diabetes can result in heart disease, neuropathy, and kidney failure. As a potential alternative, I worked towards the development of a commensal skin microbe, Staphylococcus epidermidis, engineered to sense and respond to elevated blood glucose levels. The ultimate goal is to implement within S. epidermidis a transcription-based biosensor responsive to elevated blood sugar levels that results in well-regulated and rapid production of a single-chain insulin analog. Here, I quantitatively estimated whether a skin microbe could provide enough insulin to treat Type I or Type II diabetes. I then developed a transcriptomics pipeline for characterizing organism-wide gene expression changes in response to medically relevant glucose concentrations, to facilitate the identification of glucose-inducible S. epidermidis switches. I also quantitatively explored the genome-wide transcription response of S. epidermidis to heat shock, both as a reference case for glucose response and its own merits. Finally, I explored whether conjugation could be used to reliably transfer DNA into S. epidermidis.
- 일반주제명
- Infectious diseases
- 일반주제명
- Physiology
- 일반주제명
- Hair
- 일반주제명
- Pathogens
- 일반주제명
- Diabetes
- 일반주제명
- Bacteria
- 일반주제명
- Skin diseases
- 일반주제명
- Chemistry
- 일반주제명
- Metabolism
- 일반주제명
- Teachers
- 일반주제명
- Homeostasis
- 일반주제명
- Synthetic biology
- 일반주제명
- Bioengineering
- 일반주제명
- Genetic engineering
- 일반주제명
- Clinical trials
- 일반주제명
- Glucose
- 일반주제명
- Viruses
- 일반주제명
- Chemical bonds
- 일반주제명
- Phenylketonuria
- 일반주제명
- Acne
- 일반주제명
- Pathogenesis
- 일반주제명
- Metabolites
- 일반주제명
- Biology
- 일반주제명
- Dermatology
- 일반주제명
- Genetics
- 일반주제명
- Medicine
- 일반주제명
- Pathology
- 일반주제명
- Pharmaceutical sciences
- 일반주제명
- Public health
- 일반주제명
- Virology
- 기타저자
- Stanford University.
- 기본자료저록
- Dissertations Abstracts International. 86-04B.
- 전자적 위치 및 접속
- 로그인 후 원문을 볼 수 있습니다.
MARC
008250123s2024 us c eng d■001000017163707
■00520250211152743
■006m o d
■007cr#unu||||||||
■020 ▼a9798342113441
■035 ▼a(MiAaPQ)AAI31520251
■035 ▼a(MiAaPQ)Stanfordbh947ky8221
■040 ▼aMiAaPQ▼cMiAaPQ
■0820 ▼a600
■1001 ▼aBenjamin, Kaisha Nekesa.
■24510▼aEngineering Staphylococcus Epidermidis for the Treatment of Diabetes
■260 ▼a[Sl]▼bStanford University▼c2024
■260 1▼aAnn Arbor▼bProQuest Dissertations & Theses▼c2024
■300 ▼a162 p
■500 ▼aSource: Dissertations Abstracts International, Volume: 86-04, Section: B.
■500 ▼aAdvisor: Endy, Drew.
■5021 ▼aThesis (Ph.D.)--Stanford University, 2024.
■520 ▼aDiabetes is a chronic endocrine disease characterized by insulin deficiency and resulting elevated blood glucose levels. Diabetics depend on exogenous injections of insulin to manage blood glucose levels and survive longer term. Poorly controlled diabetes can result in heart disease, neuropathy, and kidney failure. As a potential alternative, I worked towards the development of a commensal skin microbe, Staphylococcus epidermidis, engineered to sense and respond to elevated blood glucose levels. The ultimate goal is to implement within S. epidermidis a transcription-based biosensor responsive to elevated blood sugar levels that results in well-regulated and rapid production of a single-chain insulin analog. Here, I quantitatively estimated whether a skin microbe could provide enough insulin to treat Type I or Type II diabetes. I then developed a transcriptomics pipeline for characterizing organism-wide gene expression changes in response to medically relevant glucose concentrations, to facilitate the identification of glucose-inducible S. epidermidis switches. I also quantitatively explored the genome-wide transcription response of S. epidermidis to heat shock, both as a reference case for glucose response and its own merits. Finally, I explored whether conjugation could be used to reliably transfer DNA into S. epidermidis.
■590 ▼aSchool code: 0212.
■650 4▼aInfectious diseases
■650 4▼aPhysiology
■650 4▼aHair
■650 4▼aPathogens
■650 4▼aDiabetes
■650 4▼aBacteria
■650 4▼aSkin diseases
■650 4▼aChemistry
■650 4▼aMetabolism
■650 4▼aTeachers
■650 4▼aHomeostasis
■650 4▼aSynthetic biology
■650 4▼aBioengineering
■650 4▼aGenetic engineering
■650 4▼aClinical trials
■650 4▼aGlucose
■650 4▼aViruses
■650 4▼aChemical bonds
■650 4▼aPhenylketonuria
■650 4▼aAcne
■650 4▼aPathogenesis
■650 4▼aMetabolites
■650 4▼aBiology
■650 4▼aDermatology
■650 4▼aGenetics
■650 4▼aMedicine
■650 4▼aPathology
■650 4▼aPharmaceutical sciences
■650 4▼aPublic health
■650 4▼aVirology
■690 ▼a0202
■690 ▼a0485
■690 ▼a0719
■690 ▼a0306
■690 ▼a0757
■690 ▼a0369
■690 ▼a0564
■690 ▼a0571
■690 ▼a0572
■690 ▼a0573
■690 ▼a0720
■71020▼aStanford University.
■7730 ▼tDissertations Abstracts International▼g86-04B.
■790 ▼a0212
■791 ▼aPh.D.
■792 ▼a2024
■793 ▼aEnglish
■85640▼uhttp://www.riss.kr/pdu/ddodLink.do?id=T17163707▼nKERIS▼z이 자료의 원문은 한국교육학술정보원에서 제공합니다.


